Clinical Trial Update: A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure [Phase 4]

View source ↗

Summary

A Phase IV multicenter randomized cross-over trial comparing Renamezin and Kremezin in pre-dialysis chronic kidney disease patients to evaluate formulation pref…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Kremezin (AST-120)
• Renamezin

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure | Phase 4 | Status: COMPLETED